The Food and Drug Administration is evaluating Chinese-made plastic syringes used to inject or withdraw fluids from the body, citing concern that they may not provide adequate quality and performance, including their ability to deliver the correct dose of medication when used alone or with other medical devices, such as infusion pumps. Meanwhile, health care facilities should use other plastic syringes or closely monitor their use, the agency said. The concern does not currently apply to glass syringes, pre-filled syringes, or syringes used for oral or topical purposes, FDA said.

Related News Articles

Headline
The latest revisions to the Centers for Medicare & Medicaid Services’ Quality Assurance and Performance Improvement program underscore the integral role of…
Headline
Draeger Medical, Inc. is recalling its Carina Ventilators due to the presence of contaminants in the device’s airpath, which exceed acceptable levels if…
Headline
Crews are working to restore power and assess damage to a Pfizer plant in North Carolina that makes sterile injectables for U.S. hospitals after a tornado…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
The Consumer Financial Protection Bureau, Centers for Medicare & Medicaid Services, Department of Health and Human Services, and Department of the Treasury…
Headline
As urged by the AHA and its professional membership group the Association for Health Care Resource & Materials Management, the Food and Drug Administration…